Evaluation of the effects of resveratrol and bevacizumab on experimental corneal alkali burn

Burns

Volumn 39, Issue 2, 2013, Pages 326-330

  Doganay, Selim ^a   Firat, Penpe Gul ^a   Cankaya, Cem ^a   Kirimlioglu, Hale ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bevacizumab; Corneal neovascularization; Resveratrol

Indexed keywords

BEVACIZUMAB; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUSTIC BURN; CONTROLLED STUDY; CORNEA ALKALI BURN; CORNEA BURN; CORNEA EDEMA; CORNEA NEOVASCULARIZATION; DRUG INHIBITION; MALE; NONHUMAN; RABBIT; SLIT LAMP; TREATMENT OUTCOME;

ALKALIES; ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BURNS, CHEMICAL; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; EYE BURNS; MALE; RABBITS; STILBENES;

EID: 84873730190     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2012.07.018     Document Type: Article

References (30)

1. P. Lee, C.C. Wang, and A.P. Adamis Ocular neovascularization: an epidemiologic review Surv Ophthalmol 43 3 1998 245 269
2. C.H. Chang, E.E. Gabison, D. Kato, and D.T. Azar Corneal neovascularization Curr Opin Ophthalmol 12 4 2001 242 249
3. R.J. Epstein, R.D. Stulting, R.L. Hendricks, and D.M. Harris Corneal neovascularization. Pathogenesis and inhibition Cornea 6 4 1987 250 257
4. M. Murata, S. Shimuzu, S. Horiuchi, and M. Taira Inhibitory effect of triamcinolone acetonide on corneal neovascularization Graefes Arch Clin Exp Ophthalmol 244 2 2006 205 209
5. A.M. Joussen, F.E. Kruse, H.E. Volcker, and B. Kirchhof Topikal application of methotrexate for inhibition of corneal angiogenesis Graefes Arch Clin Exp Ophthalmol 237 11 1999 920 927
6. W. Shi, H. Gao, I. Xie, and S. Wang Sustained intraocular rapamycin delivery effectively prevents high risk corneal allograft rejection and neovascularization in rabbits Invest Ophthalmol Vis Sci 47 8 2006 3339 3344
7. L. Gan, P. Fagerholm, and J. Palmblad Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing Acta Ophthalmol Scand 82 5 2004 557 563
8. W. Philipp, L. Speicher, and C. Humpel Expression of vascular endothelial factor and its receptors in inflamed and vacularized human corneas Invest Ophthalmol Vis Sci 41 9 2000 2514 2522
9. A.P. Adamis, and D.T. Shima The role of vascular endothelial growth factor in ocular health and disease Retina 25 2 2005 111 118
10. S.S. Lynch, and C.M. Cheng Bevacizumab for neovascular ocular diseases Ann Pharmacother 41 4 2007 614 625
11. S.H. Byeon, Y.A. Kwon, and H.S. Oh Short-term results of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema J Ocul Pharmacol Ther 23 4 2007 387 394
12. R.F. Spaide, K. Laud, and H.F. Fine Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration Retina 26 4 2006 383 390
13. M.Y. Kahook, J.S. Schuman, and R.J. Noecker Intravitreal bevacizumab in a patient with neovascular glaucoma Ophthalmic Surg Lasers Imaging 37 2 2006 144 146
14. J.O. Mason, M.A. Albert, and R. Vail Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema Retina 26 3 2006 356 357
15. J. Dulak Nutracetical as anti-angiogenic agents, hopes and reality J Physiol Pharmacol 56 Suppl. 1 2005 51 69
16. E. Bråkenhielm, R. Cao, and Y. Cao Suppression of angiogenesis, tumour growth, and wound healing by resveratrol, a natural compound in red wine and grapes FASEB J 15 10 2001 1798 1800
17. P.C. Wu, C.C. Liu, C.H. Chen, H.K. Kou, S.C. Shen, and C.Y. Lu Inhibition of experimental angiogenesis of cornea by somatostatin Graefes Arch Clin Exp Ophthalmol 241 1 2003 63 69
18. A.N. Witmer, G.F. Vrensen, C.J. Van Noorden, and R.O. Schlingemann Vascular endothelial growth factors and angiogenesis in eye disease Prog Retin Eye Res 22 1 2003 1 29
19. R.B. Bhisitkul Vascular endothelial growth factor biology, clinical implications for ocular treatments Br J Ophthalmol 90 12 2006 1542 1547
20. V. Vincenti, C. Cassano, M. Rocchi, and G. Persico Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3 Circulation 93 8 1996 1493 1495
21. Y.S. Ng, D. Krilleke, and D.T. Shima VEGF function in vascular pathogenesis Exp Cell Res 312 5 2006 527 537
22. K.C. Yoon, K.Y. Ahn, S.E. Lee, K.K. Kim, S.K. Im, and H.J. Oh Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin Curr Eye Res 31 3 2006 215 224
23. P.J. Rosenfeld, A.A. Moshfeghi, and C.A. Puliafito Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration Ophthalmic Surg Lasers Imaging 36 4 2005 331 335
24. H. Hosseini, M. Nejabat, M. Mehryar, T. Yazdchi, A. Sedaghat, and F. Noori Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis Clin Experiment Ophthalmol 35 8 2007 745 748
25. M. Papathanassiou, P.G. Theodossiadis, V.S. Liarakos, A. Rouvas, E.J. Giamarellos-Bourboulis, and I.A. Vergados Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model Am J Ophthalmol 145 3 2008 424 431
26. F. Bock, Y. König, F. Kruse, M. Baier, and C. Cursiefen Bevacizumab (Avastin) eye drops inhibit corneal neovascularization Graefes Arch Clin Exp Ophthalmol 246 2 2008 281 284
27. R. Manzano, G. Peyman, P. Khan, P.E. Carvounis, M. Kivilcim, and M. Ren Inhibition of experimental corneal neovascularization by Bevacizumab (AVASTIN) Br J Ophthalmol 91 6 2007 804 807
28. V. Hurmeric, T. Mumcuoglu, C. Erdurman, B. Kurt, O. Dagli, and A.H. Durukan Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs Cornea 27 3 2008 357 362
29. J. Gusman, H. Malonne, and G. Atassi A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol Carcinogenesis 22 8 2001 1111 1117
30. S. Doganay, M. Borazan, M. Iraz, and Y. Cigremis The effect of resveratrol in experimental cataract model formed by sodium selenite Curr Eye Res 31 2 2006 147 153